Mark A. Emalfarb is the founder of the company. He has been a member of the company’s board of directors from October 2004 until the present, serving as its Chairman as well as President and Chief Executive Officer of the company from October 2004 until April 2007 and as Chairman and Chief Executive Officer from June 2008 until the present. Mr. Emalfarb has been a member of the board of directors of the company's wholly owned subsidiary, Dyadic International (USA), Inc., a Florida corporation ("Dyadic-Florida") from its inception until the present, served as its President, Chief Executive Officer and Chairman from its inception until April 2007, and as Chairman and Chief Executive Officer since June 2008. Since founding Dyadic-Florida in 1979, Mr. Emalfarb has successfully led and managed the evolution of Dyadic-Florida from its origins as a pioneer and leader in providing ingredients used in stone-washing of blue jeans to the discovery, development, manufacturing and commercialization of specialty enzymes used in various industrial applications and the development of an integrated technology platform based on the company’s patented and proprietary C1 fungus. Mr. Emalfarb is an inventor of over 25 U.S. and foreign biotechnology patents and patent applications resulting from discoveries related to Dyadic-Florida’s patented and proprietary C1 microorganism, and has been the architect behind its formation of several strategic research and development, manufacturing and marketing relationships with U.S. and international partners. Mr. Emalfarb earned his B.A. degree from the University of Iowa.

Mr. Faby brings to Dyadic over 20 years of financial, accounting and operational experience spanning a career that includes over 17 years with Perry Slingsby Systems, Inc. (f/k/a Perry Tritech Inc.)(“Perry”), a $113 million multi-national leader in the design and manufacture of remotely operated vehicles to the international offshore oil & gas, telecommunications, military and defense industries. During his 17 years with Perry, Mr. Faby served in various financial roles of increasing responsibility including, most recently, as its Chief Financial Officer. He holds a B.S degree in accounting from Florida State University and an MBA from Florida Institute of Technology. Mr. Faby is also a certified public accountant in Florida and a member of the American Institute of Certified Public Accountants and the Florida Institute of Certified Public Accountants.

Adam J. Morgan has been the company's Vice President General Counsel & Business Development and Secretary since joining the Company in January 2009. From December 2004 until October 2008, Mr. Morgan served as President, Chief Operating Officer and Secretary of Advance Publishers, L.C., a private distributor of licensed books and accessories in Maitland, Florida, and Executive Vice President from December 2003 to November 2004. From May 1996 to August 2003, Mr. Morgan served in various legal and business capacities for Rexall Sundown, Inc. (“Rexall”), a publicly-traded and later, privately held, manufacturer and distributor of vitamins and nutritional supplements including as Vice President New Business Development from July 2001 until August 2003. From May 1996 until July 2001, he served in various legal capacities of increasing responsibility for Rexall including, most recently, as Vice President-Legal Affairs and Assistant General Counsel. From 1990 until 1996, Mr. Morgan practiced law for several private law firms where he specialized in general corporate and securities law. Mr. Morgan earned his B.A. degree from Duke University and his law degree from the University of Connecticut School of Law. He is admitted to practice law in the States of Connecticut, Florida and New York.

Richard H. Jundzil has been the company's Director of Development & Quality since September 2008 and has held various laboratory, quality and regulatory positions of increasing responsibility since joining the Company in August 2003. Mr. Jundzil has more then 16 years of quality and operations experience in the biotechnology industry. Mr. Jundzil also is able to use his significant experience utilizing process engineering and project management fundamentals while managing the production and distribution of Dyadic's various enzyme products. Prior to joining Dyadic, Mr. Jundzil worked for ten years at Genzyme Corporation as both a researcher and process engineer producing enzymes for patients with rare genetic diseases. Mr. Jundzil earned his B.A. degree in biotechnology sciences from Boston University.

Brian E. Murdoch has been the company's Director of Sales and Marketing since September 2008 and joined the Company in January 2005. Mr. Murdoch was initially responsible for managing Dyadic's pulp and paper enzymes business and is now responsible for all of Dyadic's industrial enzyme markets. Prior to joining Dyadic, Mr. Murdoch was a Process Engineer with Dutton Engineering, a private design firm in Greenville, South Carolina from 2003 to 2005. Prior to that, Mr. Murdoch worked for five years in technical sales positions at Enzymatic Deinking Technologies (EDT), a private enzyme distributor in Norcross, Georgia. Mr. Murdoch earned his B.S degree in biochemistry with a minor in chemistry from Clemson University.